Related references
Note: Only part of the references are listed.Risk Factors of Subsequent Central Nervous System Tumors after Childhood and Adolescent Cancers: Findings from the French Childhood Cancer Survivor Study
Neige Marie Yvanne Journy et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)
Paediatric Gliomas: BRAF and Histone H3 as Biomarkers, Therapy and Perspective of Liquid Biopsies
Jean Yin Tan et al.
CANCERS (2021)
Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors-a review of research and clinical practice
Margaret C. S. Boguszewski et al.
PITUITARY (2021)
Growth Hormone Therapy Does Not Increase the Risk of Craniopharyngioma and Nonfunctioning Pituitary Adenoma Recurrence
Marco Losa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Influence of growth hormone therapy on the occurrence of a second neoplasm in survivors of childhood cancer
Cecile Thomas-Teinturier et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2020)
Hypothalamic-Pituitary Disorders in Childhood Cancer Survivors: Prevalence, Risk Factors and Long-Term Health Outcomes
Laura van Iersel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Growth Hormone's Links to Cancer
Cesar Luiz Boguszewski et al.
ENDOCRINE REVIEWS (2019)
Hypothalamic-Pituitary and Growth Disorders in Survivors of Childhood Cancer: An Endocrine Society* Clinical Practice Guideline
Charles A. Sklar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
GH Therapy in Childhood Cancer Survivors: A Systematic Review and Meta-Analysis
Shrikant Tamhane et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Pediatric Optic Pathway/Hypothalamic Glioma
Yasuo Aihara et al.
NEUROLOGIA MEDICO-CHIRURGICA (2018)
Physiologic Growth Hormone-Replacement Therapy and Craniopharyngioma Recurrence in Pediatric Patients: A Meta-Analysis
Nawaf M. Alotaibi et al.
WORLD NEUROSURGERY (2018)
Long-term safety of growth hormoneA combined registry analysis
Kirstine Stochholm et al.
CLINICAL ENDOCRINOLOGY (2018)
A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma - A final report
Astrid K. Gnekow et al.
EUROPEAN JOURNAL OF CANCER (2017)
Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study
Anthony J Swerdlow et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical Management
Dominik Sturm et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults
D. B. Allen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Treatment of growth hormone deficiency in children, adolescents and at the transitional age
Erick Richmond et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Phase II Weekly Vinblastine for Chemotherapy-Naive Children With Progressive Low-Grade Glioma: A Canadian Pediatric Brain Tumor Consortium Study
Alvaro Lassaletta et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Risk of Neoplasia in Pediatric Patients Receiving Growth Hormone Therapy-A Report From the Pediatric Endocrine Society Drug and Therapeutics Committee
Sripriya Raman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Growth hormone therapy and risk of recurrence/progression in intracranial tumors: a meta-analysis
Liang Shen et al.
NEUROLOGICAL SCIENCES (2015)
Mortality in Children with Optic Pathway Glioma Treated with Up-Front BB-SFOP Chemotherapy
Josue Rakotonjanahary et al.
PLOS ONE (2015)
Association between growth hormone therapy and mortality, cancer and cardiovascular risk: Systematic review and meta-analysis
Annalisa Deodati et al.
GROWTH HORMONE & IGF RESEARCH (2014)
Growth hormone treatment and risk of recurrence or development of secondary neoplasms in survivors of pediatric brain tumors
Zhi-Feng Wang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2014)
Survival and long-term health and cognitive outcomes after low-grade glioma
Gregory T. Armstrong et al.
NEURO-ONCOLOGY (2011)
Growth Hormone Therapy and the Risk of Tumor Recurrence after Brain Tumor Treatment in Children
Tilman R. Rohrer et al.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2010)
The First International Standard for Insulin-like Growth Factor-1 (IGF-1) for immunoassay: Preparation and calibration in an international collaborative study
C. Burns et al.
GROWTH HORMONE & IGF RESEARCH (2009)
The role of the IGF system in cancer growth and metastasis: Overview and recent insights
Amir Abbas Samani et al.
ENDOCRINE REVIEWS (2007)
Recurrence of brain tumours in patients treated with growth hormone: Analysis of KIGS (Pfizer International Growth Database)
Feyza Darendeliler et al.
ACTA PAEDIATRICA (2006)
GH replacement does not increase the risk of recurrence in patients with craniopharyngioma
N Karavitaki et al.
CLINICAL ENDOCRINOLOGY (2006)
Progression-free survival in children with optic pathway tumors: Dependence on age and the quality of the response to chemotherapy - Results of the first French prospective study for the French Society of Pediatric Oncology
V Laithier et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Share Paper
